pc 버전으로 이동 중 [시장보고서]체외진단약 관련 제휴와 라이선스 계약(2016-2024년)
체외진단약 관련 제휴와 라이선스 계약(2016-2024년)
In Vitro Diagnostic Collaboration and Licensing Deals 2016-2024
상품코드 : 1473258
리서치사 : Current Partnering, a brand of Biopharma Research Ltd.
발행일 : 2024년 05월
페이지 정보 : 영문 150+ Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,995 ₩ 5,582,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,995 ₩ 8,377,000
PDF (Multi User License - 2 to 5 Users) help
PDF 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 9,995 ₩ 13,967,000
PDF (Company Wide License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

체외진단약 관련 최근(2016-2024년) 제휴와 라이선스 계약의 동향에 대해 분석하고, 전체적인 거래 건수의 추이 및 재무면(지불 조건) 동향, 주요 기업(총 25사)에 의한 거래 성립 동향, 계약 조건 동향, 기술별 상세 동향 등을 조사했으며, 최근 주요 제휴 거래의 상세 정보를 정리하여 전해드립니다.

목차

주요 요약

제1장 서론

제2장 체외진단약 관련 거래 성립 동향

제3장 체외진단약 관련 주요 거래

제4장 체외진단약 관련 가장 활발한 거래 기업

제5장 체외진단약 관련 계약 체결 디렉토리

제6장 체외진단약 관련 거래 : 기술 종류별

KSA 24.05.14
영문 목차

영문목차

In Vitro Diagnostic Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the in vitro diagnostic deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of in vitro diagnostic deals from 2016 to 2024.

The report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostic deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 267 in vitro diagnostic deals announced since 2016 including financial terms where available including links to online deal records of actual in vitro diagnostic partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of in vitro diagnostic dealmaking.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in in vitro diagnostic dealmaking since 2016.

Chapter 3 provides an overview of the leading in vitro diagnostic deals since 2016. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in in vitro diagnostic dealmaking with a brief summary followed by a comprehensive listing of in vitro diagnostic deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of in vitro diagnostic deals signed and announced since Jan 2016, where a contract document is available in the public domain.

Chapter 6 provides a comprehensive and detailed review of in vitro diagnostic partnering deals signed and announced since Jan 2016. The chapter is organized by specific in vitro diagnostic technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in in vitro diagnostic deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

In Vitro Diagnostic Collaboration and Licensing Deals provides the reader with the following key benefits:

Report scope

In Vitro Diagnostic Collaboration and Licensing Deals includes:

Analyzing contract agreements allows due diligence of:

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in in vitro diagnostic dealmaking

Chapter 3 - Leading in vitro diagnostic deals

Chapter 4 - Most active in vitro diagnostic dealmakers

Chapter 5 - In vitro diagnostic contracts dealmaking directory

Chapter 6 - In vitro diagnostic dealmaking by technology type

Table of figures

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기